Physician profile
Nibal Saad
NPI 1376807453
$2,472.45
in general payments reported to CMS, 2019-2025
44 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $343 · 2021: $514 · 2022: $31.80 · 2023: $81.86 · 2024: $223 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.21 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $233.34 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $221.95 | 2019-2023 | Epkinly, Imbruvica |
| Janssen Biotech, INC. | $187.95 | 2019-2021 | |
| Astellas Pharma US INC | $175.94 | 2019-2020 | |
| Seagen INC. | $168.28 | 2021-2023 | Adcetris |
| E.R. Squibb & Sons, L.L.C. | $150.72 | 2019-2025 | Reblozyl, Opdivo |
| Amgen INC. | $113.32 | 2019-2024 | |
| Clovis Oncology, INC. | $111.01 | 2019-2020 | |
| Inari Medical, INC. | $98.32 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $90.42 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $72.95 | 2019-2021 | |
| Pfizer INC. | $72.74 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $63.74 | 2019-2021 | |
| Genzyme Corporation | $61.23 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $53.82 | 2019-2025 |
Show all 42 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nibal Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.